Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to ...

Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...

A team led by David Boies at Boies Schiller Flexner, Bill Carmody at Susman Godfrey and John Yanchunis at Morgan & Morgan ...

As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an ...

The Data Protection Com­mission (DPC) yesterday launched a national aware­ness campaign to protect and promote the data privacy ...